Verastem, Inc. (2VSA.F)

EUR 4.28

(-35.15%)

Eps Summary of Verastem, Inc.

  • Verastem, Inc.'s latest annual eps in 2022 was -4.57 USD , up 6.73% from previous year.
  • Verastem, Inc.'s latest quarterly eps in 2024 Q2 was -0.31 USD , up 75.4% from previous quarter.
  • Verastem, Inc. reported an annual eps of -4.90 USD in 2021, up 7.55% from previous year.
  • Verastem, Inc. reported an annual eps of -5.30 USD in 2020, up 77.93% from previous year.
  • Verastem, Inc. reported a quarterly eps of -1.26 USD for 2024 Q1, down 0.0% from previous quarter.
  • Verastem, Inc. reported a quarterly eps of -0.75 USD for 2023 Q3, up 45.26% from previous quarter.

Annual Eps Chart of Verastem, Inc. (2022 - 2011)

Historical Annual Eps of Verastem, Inc. (2022 - 2011)

Year Eps Eps Growth
2022 -4.57 USD 6.73%
2021 -4.90 USD 7.55%
2020 -5.30 USD 77.93%
2019 -24.01 USD -91.47%
2018 -12.54 USD 40.79%
2017 -21.18 USD -79.19%
2016 -11.82 USD 38.82%
2015 -19.32 USD 22.16%
2014 -24.82 USD -13.85%
2013 -21.80 USD -6.6%
2012 -20.45 USD -152.16%
2011 -8.11 USD 0.0%

Peer Eps Comparison of Verastem, Inc.

Name Eps Eps Difference
BioNTech SE 3.87 EUR 218.088%
CureVac N.V. -1.18 EUR -287.288%
Biotest Aktiengesellschaft 3.21 EUR 242.368%
Biotest Aktiengesellschaft 3.21 EUR 242.368%
BRAIN Biotech AG -0.38 EUR -1102.632%
Formycon AG 4.76 EUR 196.008%
Heidelberg Pharma AG -0.44 EUR -938.636%
Medigene AG -0.66 EUR -592.424%